z-logo
open-access-imgOpen Access
Combination of two target agonists of the thrombopoietin and thrombopoietin receptor in the treatment of elderly patients with refractory immune thrombocytopenia
Author(s) -
Jundong Zhang,
Zining Wang,
Hao Chen,
Xuechun Lu
Publication year - 2022
Publication title -
cancer pathogenesis and therapy
Language(s) - English
Resource type - Journals
ISSN - 2949-7132
DOI - 10.1016/j.cpt.2022.09.005
Subject(s) - thrombopoietin , thrombopoietin receptor , eltrombopag , agonist , platelet , medicine , adverse effect , refractory (planetary science) , pharmacology , receptor , immune thrombocytopenia , romiplostim , immunology , haematopoiesis , biology , microbiology and biotechnology , stem cell , astrobiology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom